The Value of Targeting CXCR4 with 68Ga-Pentixafor PET/CT for Subtyping Primary Aldosteronism.

Yanqing ZhengTingting LongNing PengMengling ZhenQianwen YeZhen ZhangYao HeZhi ChenYu GanMin LuoChun LiZehao LiuMin GuoMin WangXianghang LuoShuo Hu Longfei Liu Tiejian Jiang

Published in: The Journal of clinical endocrinology and metabolism (2023)

68Ga-Pentixafor PET/CT is a reliable and non-invasive functional imaging technique that demonstrates high accuracy in classifying PA and provides valuable guidance for clinical treatment decision-making.

Keyphrases

pet ct
decision making
positron emission tomography
high resolution
cancer therapy
cell migration
computed tomography
photodynamic therapy